Favorable response to pembrolizumab in granulocyte colony-stimulating factor-producing upper urinary tract urothelial carcinoma.

Hiroki TakedaRyuji MatsumotoEmi TakakuwaKanta HoriTakuya MoriguchiShuhei YamadaHiroshi KikuchiTakahiro OsawaTakashige AbeNobuo Shinohara

Published in: IJU case reports (2021)

Pembrolizumab may be a treatment option for advanced granulocyte colony-stimulating factor-producing upper urinary tract urothelial carcinoma.

Keyphrases